These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28667454)

  • 1. Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.
    Valzania C; Biffi M; Bonfiglioli R; Fallani F; Martignani C; Diemberger I; Ziacchi M; Frisoni J; Tomasi L; Fanti S; Rapezzi C; Boriani G
    J Nucl Cardiol; 2019 Feb; 26(1):123-132. PubMed ID: 28667454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy.
    Valzania C; Fallani F; Gavaruzzi G; Biffi M; Martignani C; Diemberger I; Bertini M; Domenichini G; Ziacchi M; Gadler F; Eriksson MJ; Braunschweig F; Franchi R; Branzi A; Rapezzi C; Boriani G
    Am J Cardiol; 2010 Aug; 106(3):389-94. PubMed ID: 20643252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.
    Gierula J; Cubbon RM; Jamil HA; Byrom R; Baxter PD; Pavitt S; Gilthorpe MS; Hewison J; Kearney MT; Witte KK
    Europace; 2013 Nov; 15(11):1609-14. PubMed ID: 23736807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular function and long-term clinical outcomes after cardiac resynchronization therapy: A cardiovascular magnetic resonance study.
    Zegard A; Okafor O; Moody W; Marshall H; Qiu T; Stegemann B; Beadle R; Leyva F
    Pacing Clin Electrophysiol; 2022 Sep; 45(9):1075-1084. PubMed ID: 35899803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Prediction of Cardiac Resynchronization Therapy Response Requires Analysis of Both Mechanical Dyssynchrony and Right Ventricular Function: A Combined Analysis of Patient Data and Computer Simulations.
    van Everdingen WM; Walmsley J; Cramer MJ; van Hagen I; De Boeck BWL; Meine M; Delhaas T; Doevendans PA; Prinzen FW; Lumens J; Leenders GE
    J Am Soc Echocardiogr; 2017 Oct; 30(10):1012-1020.e2. PubMed ID: 28801203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular function assessed by cardiac magnetic resonance predicts the response to resynchronization therapy.
    Manca P; Cossa S; Matta G; Scalone A; Tola G; Schintu B; Setzu A; Melis M; Giardina A; Corda M; Sinagra G; Porcu M
    J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):299-304. PubMed ID: 32108126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between right ventricular mechanical dyssynchrony and cardiac resynchronization therapy in patients with nonischemic dilated cardiomyopathy.
    Mukherjee A; Patel CD; Roy A; Sharma G; Naik N
    Nucl Med Commun; 2016 Oct; 37(10):1016-23. PubMed ID: 27295307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
    PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise.
    Boriani G; Fallani F; Martignani C; Biffi M; Saporito D; Greco C; Ziacchi M; Levorato M; Pontone G; Valzania C; Diemberger I; Franchi R; Branzi A
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S11-4. PubMed ID: 15683474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.
    Alpendurada F; Guha K; Sharma R; Ismail TF; Clifford A; Banya W; Mohiaddin RH; Pennell DJ; Cowie MR; McDonagh T; Prasad SK
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):68. PubMed ID: 22040270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy.
    Bleeker GB; Schalij MJ; Nihoyannopoulos P; Steendijk P; Molhoek SG; van Erven L; Bootsma M; Holman ER; van der Wall EE; Bax JJ
    J Am Coll Cardiol; 2005 Dec; 46(12):2264-9. PubMed ID: 16360056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular systolic function and cardiac resynchronization therapy.
    Burri H; Domenichini G; Sunthorn H; Fleury E; Stettler C; Foulkes I; Shah D
    Europace; 2010 Mar; 12(3):389-94. PubMed ID: 19966321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.
    Lang NN; Badar AA; Pettit SJ; Templeton S; Connelly DT; Gardner RS
    Biomark Med; 2014; 8(6):797-806. PubMed ID: 25224936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
    J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.